Differences of Respiratory Rate Between Salbutamol and Aminofilin in Exacerbation Asthma

Amelia Lorensia; Zullies Ikawati; Tri Murti Andayani; Daniel Maranatha

doi:10.24198/ijpst.v6i3.17034

Differences of Respiratory Rate Between Salbutamol and Aminofilin in Exacerbation Asthma

Amelia Lorensia, Zullies Ikawati, Tri Murti Andayani, Daniel Maranatha

Abstrak

Exacerbation of asthma is a progressive step in progressive breathing, coughing, wheezing, breathing. In Indonesia salbutamol nebulation is used for the therapy of the first exacerbation attack. In addition, intravenous aminophylline is also recommended as a therapy, even if the use of aminophylline abroad is reduced due to its smaller effectiveness and often leads to greater unwanted reaction events. The effectiveness of asthma exacerbation therapy needs to be monitored and one of the monitoring parameters that is easily seen is the rate of breath.The aim of this study was to investigate the difference in respiratory rate values using salbutamol nebulisation and intravenous aminophylline in patients with asthma exacerbations in hospitals in Surabaya. The research was conducted by using quasi experimental method and data collection by purposive sampling. Analysis of the data to be used is a independent t-test. The results showed that the salbutamol group decreased respiratory rate by 50.00%, there were also patients who experienced an increase of breath rate of 13.64%. In the aminophylline group experienced a decrease in respiratory rate of 43.75% with an increase of breath rate of 18.75%. From the results of the study, it is necessary to monitor the effectiveness and the need to monitor the unwanted reactions of both treatments so that the therapies produced in the treatment of asthma exacerbations are more effective.

Key words: Aminophylline, exacerbation asthma, respiratory rate, salbutamol

Teks Lengkap:

PDF

Referensi

The Global Initiative for Asthma. Update of the GINA report:Global strategy for asthma management and prevention,2017.

Roden DM, Wilke RA, Kroemer HK, Stein CM. Pharmacogenomics:The Genetics of Variable Drug Responses. Circulation.2011;123(15):1661-1670.

Smith I, Mackay J, Fahrid N, Krucheck D. Respiratory Rate Measurement:a Comparison of Methods. British Journal of Helahcare Assistants.2011;5(1):18-23.

Adams JY, Sutter ME, Albertson TE. The Patient with Athma in the Emergency Departement. Clinic Rev Allerg Immunol.2012;43(2-1):14-29.

Soubra SH, Kalapalatha K, Guntupalli. Acute Respiratory Failure in Asthma. 2009;9(4):225-234.

Stroeder J, Evans C, Mansell H. Corticosteroid-induced bradycardia. Can Pharm J (Ott).2015;148(5):235–240.

Khorfan FM, Smith P, Watt S, Barber KR. Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.Chest. 2011;140(6):1466-1472.

Kenyon CC, Fieldston ES, Luan X, Keren R, Zorc JJ. Safety and Effectiveness of Continuous Aerosolized Albuterol in the Non–Intensive Care Setting. Pediatrics.2014;134(4):e976-e982.

Prakash S, Sharma S, Miglani S, Gogia AR. Management of Intraoperative Penile Erection with Salbutamol Aerosol. Journal of Anaesthesiolog Clinical Pharmacology.2012;28(3):402-403.

Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev.2010;(12):CD000432.

Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CMT. Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity. Paediatr Drugs.2014; 16(2):169-177.

Bioh G, Gallagher MM, Prasad U. Survival of a Highly Toxic Dose of Caffeine. BMJ Case Rep.2013; bcr2012007454.

Kementerian Kesehatan RI. Keputusan Menteri Kesehatan Republik Indonesia Nomor 312/MENKES/SK/IX/2013, tentang Daftar Obat Essensial 2013. Jakarta: Kementerian Kesehatan RI; 2013.

Lorensia A, Wahjuningsih E, Canggih B, Lisiska N. Pharmacist’s Strategies in Treating Asthma Bronchiale Outpatient. Jurnal of Tropical Pharmacy and Chemistry.2011;1(3):177-191.

Lorensia A, Amalia RA. Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro. Jurnal Ilmiah Manuntung. 2015;1(1):8-18.

Lorensia A, Wahjuningsih E, Supriadi, 2012. Keamanan Penggunaan Aminofilin pada Asma di Rumah Sakit Delta Surya Sidoarjo. Indonesia journal of Clinical Pharmacy.2012;1(4):154-161.

Lorensia A, Wijaya RI. Hubungan Jumlah Obat yang Digunakan Terhadap Risiko Terjadinya Drug-Related Problems pada Pasien Asma di Suatu Rumah Sakit di Surabaya. Jurnal of Tropical Pharmacy and Chemistry. 2016;3(3):232-238.

Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. Comparison of Electrolyte Disturbance of Using Intravenous Aminophylline Versus Nebulization Salbutamol for Exacerbation Asthma in Surabaya, Indonesia. International Journal of Pharmaceutical and Clinical Research.2016;8(4):221-228.

Majumdar S, Mueller-Spaeth, Sloan KB. Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.2012;13(3):853-62.

Hocaoğlu N, Yıldıztepe E, Bayram B, Aydın B, Tunçok Y, Kalkan S. Demographic and Clinical Characteristics of Theophylline Exposures between 1993 and 2011. Balkan Med J.2014;31(4):322–327.

Blix HS, Viktil KK, Moger TA, Reikvam A. Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients.2010;8(1):50-55.

Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. Analisis Kejadian Leukositosis Pasca Terapi Aminofilin Intravena Dibandingkan dengan Salbutamol Nebulasi pada Pasien Eksaserbasi Asma. Indonesia journal of Clinical Pharmacy. 2016;5(3):149-159.

Philip KE, Pack E, Cambiano V, Rollmann H, Weil S, O’Beirne J. The Accuracy of Respiratory Rate Assessment by Doctors in a London Teaching Hospital: a Cross-sectional study. J Clin Monit Comput. 2015;29(4):455-460.

Cekici L, Valipour A, Kohansal R, Burghuber OC. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. Br J Clin Pharmacol.2009;67(4):394–402.

Billington CK, Penn RB, Hall IP. B2-Agonists. Handb Exp Pharmacol. 2017;233:23-40.

Mahemuti G, Zhang H, Li J, Tieliwaerdi N, Ren L. Efficacy and side effects of intravenous theophylline in acute asthma: a systematic review and meta-analysis.Drug Des Devel Ther. 2018;12:99–120.

Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2012;12:CD002742.

National Center for Chronic Disease Prevention and Health Promotion. Data source with asthma content: Behavioral risk factor surveillance system (BRFSS); 2011.

National Asthma Council Australia. Asthma Management Handbook [diunduh 28 November 2017]. Tersedia dari: https: //www.nationalasthma.org.au/health-prof essionals/australian-asthma-hand book

Fong N. Aminophylline/theophylline: Loading and maintenance dose. NHS Trust: East Lancashire Hospitals;2011.

Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma, British Thoracic Society;2011.

Chester JG, Rudolph JL. Vital Signs in Older Patients: Age-Related Changes. J Am Med Dir Assoc.2011;12(5):337-343.

Grassmann M, Vlemincx E, Leupoldt AV, Mittelstadt JM, Bergh OV. Respiratory Changes in Response to Cognitive Load: A Systematic Review. Neural Plasticity.2016;8146809:1-16.

Vlemincx E, Diest V, Bergh VD. A sigh following sustained attention and mental stress: effects on respiratory variability. Physiol Behav.2012;107(1):1-6.

Hamdasmalani MD, DeBari V, Bithoney WG, Gold N. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care.2005;21(7):415-9.

Troosters T, Dupont L, Bott J, Hansen K. Your Lungs anda Exercise. Breathe (Sheff).2016;12(1):97-100.

DOI: https://doi.org/10.24198/ijpst.v6i3.17034